Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,187
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
A study in healthy men and women to test whether BI 1569912 influences the amount of repaglinide, midazolam and bupropion in the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to compare the amount of vicadrostat and empagliflozin in the blood when taken separately and together
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3009947 is taken up into the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how BI 1569912 is processed in the body
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how BI 1584862 is processed in the body
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how BI 1839100 is taken up and handled by the body
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how bosentan influences the amount of nerandomilast in the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how bosentan influences the amount of zongertinib in the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how different doses of BI 3031185 are tolerated and how food influences the amount of BI 3031185 in the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how itraconazole influences the amount of BI 764198 in the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how well different doses of BI 3731579 are tolerated
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how well different doses of BI 3776528 are tolerated
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test how well different doses of BI 3821001 are tolerated
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test whether BI 1815368 influences the amount of metformin in the body
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test whether carbamazepine influences the amount of nerandomilast in the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test whether esomeprazole influences the amount of BI 3000202 in the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test whether food influences the amount of BI 3731579 in the blood
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood
Boehringer Ingelheim International GmbH
Pharmacokinetic trial
1 trial -
A study in healthy men to test whether zongertinib influences the amount of 4 other medicines (dabigatran, rosuvastatin, metformin, and furosemide) in the blood
Boehringer Ingelheim International GmbH
Pharmacokinetic trial
1 trial -
A study in healthy people or otherwise healthy but overweight or obese to compare 2 formulations of survodutide given in different ways, either as a pre-filled syringe or a pen-like injector
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy people or otherwise healthy with overweight or obesity to compare 2 formulations of survodutide given in different ways, either as a pre-filled syringe or a pen-like injector
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy people to compare how 2 different formulations of survodutide are taken up by the body
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy people to compare how 2 different formulations of survodutide are taken up in the body
Boehringer Ingelheim International GmbH
Healthy volunteer trial
1 trial -
A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body
Boehringer Ingelheim International GmbH
Pharmacokinetic trial
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources